Perillic acid inhibits Ras/MAPkinase-driven IL-2 production in human T lymphocytes

Biochemical and Biophysical Research Communications

Volumn 241, Issue 3, 1997, Pages 720-725

  Schulz, Stefan ^a   Reinhold, Dirk ^a   Schmidt, Harald ^a   Ansorge, Siegfried ^a   Höllt, Volker ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Cytokines; d limonene; Monoterpenes; Protein prenylation; T cells

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; LIMONENE; MITOGEN ACTIVATED PROTEIN KINASE; PERILLIC ACID; RAS PROTEIN; T LYMPHOCYTE RECEPTOR; TERPENE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031590712     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7884     Document Type: Article

References (34)

1. Crowell P. L., Gould M. N. Crit. Rev. Oncog. 5:1994;1-22.
2. Wattenberg L. W. Cancer Res. 45:1985;1-8.
3. Elegbede J. A., Elson C. E., Qureshi A., Tanner M. A., Gould M. N. Carcinogenesis. 5:1984;661-664.
4. Russin W. A., Hoesly J. D., Elson C. E., Tanner M. A., Gould M. N. Carcinogenesis. 10:1989;2161-2164.
5. Wattenberg L. W., Sparnins V. L., Barany G. Cancer Res. 49:1989;2689-2692.
6. Wattenberg L. W., Cocccia J. B. Carcinogenesis. 12:1991;115-117.
7. Crowell P. L., Kennan W. S., Haag J. D., Ahmad S., Vedejs E., Gould M. N. Carcinogenesis. 13:1992;1261-1264.
8. Elson C. E., Maltzmann T. H., Boston J. L., Tanner M. A., Gould M. N. Carcinogenesis. 9:1988;331-332.
9. Maltzmann T. H., Hurt L. M., Elson C. E., Tanner M. A., Gould M. N. Carcinogenesis. 10:1989;781-783.
10. Gould M. N., Moore C. J., Zhang R., Wang B., Kennan W. S., Haag J. D. Cancer Res. 54:1994;3540-3543.
11. Haag J. D., Lindstrom M. J., Gould M. N. Cancer Res. 52:1992;4021-4026.
12. Crowell P. L., Chang R. R., Ren Z., Elson C. E., Gould M. N. J. Biol. Chem. 266:1991;17679-17685.
13. Crowell P. L., Ren Z., Lin S., Vedejs E., Gould M. N. Biochem. Pharmacol. 47:1994;1405-1415.
14. Clegg R. J., Middleton B., Bell G. D., White D. A. Biochem. Pharmacol. 29:1980;2125-2130.
15. Clegg R. J., Middleton B., Bell G. D., White D. A. J. Biol. Chem. 257:1982;2294-2299.
16. Ren Z., Gould M. N. Cancer Lett. 76:1994;185-190.
17. Gelb M. H., Tamanoi F., Yokoyama K., Ghomashchi F., Esson K., Gould M. N. Cancer Lett. 91:1995;169-175.
18. Hohl R. J., Lewis K. J. Biol. Chem. 270:1995;17508-17512.
19. Schulz S., Bühling F., Ansorge S. Eur. J. Immunol. 24:1994;301-306.
20. Reinhold D., Bank U., Bühling F., Lendeckel U., Ulmer A. J., Flad H. D., Ansorge S. Cytokine. 6:1994;382-388.
21. Schulz S., Nyce J. W. Cancer Res. 51:1991;6563-6567.
22. Schulz S., Klann R. C., Schönfeld S., Nyce J. W. Cancer Res. 52:1992;1372-1376.
23. Bourne H. R., Sanders D. A., McCormick F. Nature. 348:1991;125-132.
24. Hall A. Science. 249:1990;635-640.
25. Rayter S. I., Woodrow M., Lucas S. C., Cantrell D. A., Downward J. EMBO J. 11:1992;4549-4556.
26. Baldari C. T., Macchia G., Telford J. L. J. Biol. Chem. 267:1992;4289-4291.
27. Izquierdo-Pastor M., Reif K., Cantrell D. Immunol. Today. 16:1995;159-164.
28. Hancock J. T., Magee A. I., Childs J. E., Marshall C. J. Cell. 57:1989;1167-1177.
29. Schafer W. R., Kim R., Sterne L. R., Throner J., Kim S-H., Rine J. Science. 245:1989;379-384.
30. Lyons R. M., Keski-Oja J., Moses H. L. J. Cell Biol. 106:1988;1659-1665.
31. Jirtle R. L., Haag J. D., Ariazi E. A., Gould M. N. Cancer Res. 53:1993;3849-3852.
32. Cuthbert J. A., Lipsky P. E. J. Biol. Chem. 265:1990;18568-18575.
33. Cuthbert J. A., Lipsky P. E. Cancer Res. 55:1995;1732-1740.
34. Waldmann T. A. Immunol. Today. 14:1993;264-270.